David Hung
CIK 1310880 · PRESIDENT AND CEO · last filed 2026-06-05
David Hung is a PRESIDENT AND CEO who has filed 88 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for NVCR, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$72.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $32.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$31.96M
8
88
-$71.96M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVCR | Director | 32,075 | $17.78 | $570.3K | -$63.7K | 11 | 2026-06-05 |
| NUVB | PRESIDENT AND CEO | — | $4.92 | — | $0 | 1 | 2026-03-03 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | PRESIDENT AND CEO | 59,281,054 | $0.01 | $302.3K | $1.71M | 8 | 2025-06-18 |
| ESTA | Director | — | $82.14 | — | $0 | 2 | 2020-05-27 |
| MEDIVATION, INC. (MDVN) Delisted | President and CEO | 1,709,497 | — | — | -$73.04M | 50 | 2016-09-19 |
| Acer Therapeutics Inc. (OPXAW) Delisted | Director | 0 | — | — | -$123.4K | 9 | 2011-04-07 |
| Acer Therapeutics Inc. (OPXA) Delisted | Director | — | — | — | $0 | 1 | 2007-06-21 |
| MDV | President and CEO | 1,710,711 | $18.35 | $31.39M | -$445.0K | 1 | 2007-03-20 |
Recent Filings
88 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | NVCR | Grant (A) | +11,610 | $0 | EDGAR |
| 2026-06-03 | NVCR | Sell (S) | −2,945 | -$46.4K | EDGAR |
| 2026-03-03 | NUVB | Grant (A) | — | $0 | EDGAR |
| 2025-06-18 | Nuvation Bio Inc. (NUVB.WS) Delisted | Buy (P) | +500,000 | $893.5K | EDGAR |
| 2025-06-06 | NVCR | Grant (A) | +11,215 | $0 | EDGAR |
| 2025-06-04 | NVCR | Sell (S) | −999 | -$17.3K | EDGAR |
| 2025-04-08 | Nuvation Bio Inc. (NUVB.WS) Delisted | Buy (P) | +500,000 | $820.2K | EDGAR |
| 2025-03-04 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | NVCR | Grant (A) | +4,053 | $0 | EDGAR |
| 2024-03-04 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |